000 04217cam a2200589Ii 4500
001 on1246225446
003 OCoLC
005 20220526095015.0
006 m d
007 cr |n|||||||||
008 210415s2021 sz o 001 0 eng d
020 _a9783030626327
_q(electronic bk.)
020 _a3030626326
_q(electronic bk.)
020 _z9783030626310
020 _z3030626318
024 7 _a10.1007/978-3-030-62632-7
_2doi
035 _a2916228
035 _a(OCoLC)1246225446
040 _aYDX
_beng
_erda
_cYDX
_dGW5XE
_dOCLCO
_dOCLCF
_dN$T
049 _aMAIN
050 4 _aRC669
072 7 _aMJD
_2bicssc
072 7 _aMED010000
_2bisacsh
072 7 _aMJD
_2thema
082 0 4 _a616.1/0654
_223
245 0 0 _aNutraceuticals and cardiovascular disease :
_ban evidence-based approach /
_cArrigo F.G. Cicero, Manfredi Rizzo, editors.
264 1 _aCham :
_bHumana Press,
_c[2021]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aContemporary cardiology,
_x2196-8969
500 _aIncludes index.
505 0 _aChapter 1. Introduction to Cardiovascular Disease Epidemiology and Risk Factors -- Chapter 2. Definition of Nutraceuticals (Both Scientific and Legal) -- Chapter 3. Evidence-based Approach to Nutraceuticals in Cardiovascular Medicine -- Chapter 4. Dietary Patterns and Cardiovascular Disease Risk: From Epidemiology to Intervention -- Chapter 5. Single Dietary Components and Cardiovascular Disease Risk: From Epidemiology to Intervention -- Chapter 6. Nutraceuticals for Dyslipidemia Management -- Chapter 7. Nutraceuticals for Hypertension Management -- Chapter 8. Nutraceuticals for Management of Insulin Resistance -- Chapter 9. Nutraceuticals Supporting Body Weight Loss -- Chapter 10. Nutraceuticals for Non-alcoholic Fatty Liver Disease Management -- Chapter 11. Nutraceuticals for Homocysteine Reduction -- Chapter 12. Nutraceuticals Supporting Cognitive Function in Mild Cognitive Impairment -- Chapter 13. Nutraceuticals Supporting Heart Function in Heart Failure -- Chapter 14. Nutraceuticals with Potential Adverse Cardiovascular Events or Pharmacological Interaction with Cardiometabolic Drugs.
520 _aThis book provides an evidence-based approach for the clinical use of nutraceuticals in the prevention and management of cardiovascular disease. It examines cardiovascular disease epidemiology, risk factors, and the role of dietary patterns. Clinical chapters discuss the use of nutraceuticals in the management of medical conditions such as dyslipidemia, hypertension, insulin resistance, and heart failure. Each chapter contains a short epidemiological background; a list of relevant active compounds and their efficacy, tolerability, and safety; and suggestions for prescribers. This book is a practical guide with the best clinical evidence supporting the use of nutraceuticals in cardiology. Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice is an essential resource for physicians, residents, fellows, and medical students in cardiology, clinical nutrition, dietetics, and internal medicine.
588 0 _aOnline resource; title from PDF title page (SpringerLink, viewed April 15, 2021).
590 _aAdded to collection customer.56279.3
650 0 _aCardiovascular system
_xDiseases
_xNutritional aspects.
650 0 _aCardiovascular system
_xDiseases
_xDiet therapy.
650 0 _aFunctional foods.
650 7 _aCardiovascular system
_xDiseases
_xDiet therapy.
_2fast
_0(OCoLC)fst00847190
650 7 _aCardiovascular system
_xDiseases
_xNutritional aspects.
_2fast
_0(OCoLC)fst00847201
650 7 _aFunctional foods.
_2fast
_0(OCoLC)fst00936070
655 4 _aElectronic books.
700 1 _aCicero, Arrigo F. G.,
_eeditor.
700 1 _aRizzo, Manfredi,
_eeditor.
776 0 8 _iPrint version:
_z3030626318
_z9783030626310
_w(OCoLC)1197847849
830 0 _aContemporary cardiology (Totowa, N.J.)
_x2196-8969
850 _aSHTL
856 4 0 _3EBSCOhost
_uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2916228
942 _2nlm
_cEBK
999 _c36099
_d36099